JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area cell cycle c myc'

Search results for: 'research area cell cycle c myc'

A4118 Hesperadin

1 Citation

Target: Aurora Kinases

Summary: Aurora B kinase inhibitor

≥25.85 mg/mL
A8182 3-Deazaneplanocin A (DZNep) hydrochloride

1 Citation

Target: EZH2

Summary: SAHH and EZH2 inhibitor

insoluble in EtOH; ≥14.94 mg/mL
A4056 AT13387

Target: HSP90

Summary: Hsp90 inhibitor

insoluble in H2O; ≥13.25 mg/mL
A8325 Tivantinib (ARQ 197)

2 Citation

Target: MET

Summary: C-Met inhibitor,non-ATP-competitive

≥18.47 mg/mL
A3449 GSK343

1 Citation

Target: EZH2

Summary: EZH2 inhibitor,potent,selective and cell permeable
B1577 C646

1 Citation

Target: p300

Summary: HAT p300-CBP inhibitor,cell-permeable

insoluble in H2O; ≥11.14 mg/mL
A2678 SU11274

2 Citation

Target: MET

Summary: C-Met inhibitor,potent and selective

≥28.4 mg/mL
A1912 Lomeguatrib

Target: O6-methylguanine-DNA-methyl-transferase (MGMT)

Summary: MGMT inhibitor

≥50 mg/mL
A8219 Gefitinib (ZD1839)

3 Citation

Target: EGFR

Summary: Selective EGFR inhibitor

≥22.34 mg/mL
A8178 Panobinostat (LBH589)

10 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL